Literature DB >> 3008886

Human macrophage maturation and heterogeneity: analysis with a newly generated set of monoclonal antibodies to differentiation antigens.

R Andreesen, K J Bross, J Osterholz, F Emmrich.   

Abstract

We have analyzed the expression of late differentiation antigens during terminal in vitro maturation of human macrophages (M phi) from blood monocytes (MO) in comparison to their distribution among mature M phi residing in various tissue sites. By immunizing mice with M phi derived from blood MO by culture on hydrophobic Teflon foils, monoclonal antibodies (mAbs) were developed (MAX.1, MAX.2, MAX.3, MAX.11) that reacted with lineage-restricted differentiation antigens. These antigens were expressed exclusively on M phi or were markedly increased after in vitro differentiation. The only overlap to another hemopoietic cell lineage was observed with MAX.3, which is shared by platelets and megakaryocytes. In the course of M phi maturation in vitro, the MAX.1 and MAX.3 antigens are detected within the cytoplasm two days before they appear on the cell surface. In contrast, the MAX.11 antigen is expressed simultaneously in the cytoplasm and at the cell surface, is found in varying degrees on a minor portion of blood MO and U937 cells, and is expressed rapidly at high density during early M phi differentiation in vitro. Among conventional mAbs that do not react with MO we found those against the transferrin (TF)-receptor, the BA-2, and the PCA1 antigen to label M phi. M phi matured in vivo and isolated from body fluids were positive with some but not all MAX mAbs. Distinctive patterns were observed with pulmonary M phi, exudate M phi from pleural and peritoneal effusions, synovial fluids, and early lactation milk. M phi from the alveolar space, for example, constantly expressed the MAX.2 antigen but not the MAX.3 antigen. Pleural effusion M phi, however, did not react with the MAX.1 mAb, but in most cases, it did react with the MAX.3 mAb. The detection of novel differentiation antigens, all expressed on monocyte-derived M phi but differently expressed on site-specific M phi in situ, underlines the remarkable heterogeneity among human M phi. The expression of these antigens is flexible because those MAX antigens that were not expressed in situ could be induced if cells from distinct tissue sites were cultured in vitro for several days. MAX mAbs may be of potential value to study both the sequential stages of maturation within the M phi lineage as well as differential developments induced by various culture conditions in parallel to environmental factors in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3008886

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Characterization of MAX.3 antigen, a glycoprotein expressed on mature macrophages, dendritic cells and blood platelets: identity with CD84.

Authors:  S W Krause; M Rehli; S Heinz; R Ebner; R Andreesen
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

2.  Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection.

Authors:  K C McCullough; S Basta; S Knötig; H Gerber; R Schaffner; Y B Kim; A Saalmüller; A Summerfield
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

3.  Pre- and post-embedding immunoelectron microscopy of Ki-M1P immunoreactive germinal center macrophages using ultra-small gold probes with silver enhancement.

Authors:  T H Larsen; A C Feller
Journal:  Histochem Cell Biol       Date:  1996-03       Impact factor: 4.304

4.  Phenotypic and functional characterization of a new human macrophage cell line K1m demonstrating immunophagocytic activity and signalling through HLA class II.

Authors:  D P Dialynas; M J Lee; L E Shao; P C Tan; J Yu
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

5.  Application of a novel immunization protocol to the production of monoclonal antibodies specific for macrophages in human placenta.

Authors:  A D Nash; S Uren; C S Hawes; W Boyle
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

6.  Differences in expression of monocyte/macrophage surface antigens in peripheral blood and bronchoalveolar lavage cells in interstitial lung diseases.

Authors:  H C Hoogsteden; P T van Hal; J M Wijkhuijs; W Hop; C Hilvering
Journal:  Lung       Date:  1993       Impact factor: 2.584

7.  Influence of 1,25-(OH)2 vitamin D3 and gamma interferon on the phenotype of human peripheral blood monocyte-derived macrophages.

Authors:  L W Poulter; G A Rook; J Steele; A Condez
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  The phenotype of human placental macrophages and its variation with gestational age.

Authors:  J Goldstein; M Braverman; C Salafia; P Buckley
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

9.  Impaired accessory cell function in a human dendritic cell line after human immunodeficiency virus infection.

Authors:  Prarthana Beuria; Houchu Chen; Michael Timoney; Kirk Sperber
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

10.  Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: toxicity and immunomodulatory effects.

Authors:  A Faradji; A Bohbot; M Schmitt-Goguel; N Roeslin; S Dumont; M L Wiesel; C Lallot; M Eber; J Bartholeyns; P Poindron
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.